1.An Aggressive Large Epithelioid Hemangioendothelioma of the Anterior Mediastinum in a Young Woman.
Roman DUTTA ; Harish PAL ; Garima GARG ; Sambit MOHANTY
The Korean Journal of Thoracic and Cardiovascular Surgery 2018;51(6):419-422
Hemangioendothelioma is a rare vascular tumor with involvement of the liver, brain, long bones, and lung. Among the 6 histological subtypes, epithelioid hemangioendothelioma (EHE) is the most aggressive. Its occurrence in the mediastinum is quite rare, and very few cases have been documented. The reported cases in the literature have described difficulties in the preoperative diagnosis due to the unusual histological appearance of the tumor. Immunohistochemistry remains the mainstay for a definitive diagnosis. Due to its low incidence, there is no standard treatment for mediastinal EHE, but curative resection is the preferred treatment option where possible, with chemotherapy used as an adjuvant treatment or in cases of widespread inoperable disease. The present case study describes an aggressive EHE occurring in an 18-year-old woman in the anterior mediastinum.
Adolescent
;
Brain
;
Diagnosis
;
Drug Therapy
;
Female
;
Hemangioendothelioma
;
Hemangioendothelioma, Epithelioid*
;
Humans
;
Immunohistochemistry
;
Incidence
;
Liver
;
Lung
;
Mediastinum*
;
Vascular Neoplasms
2.Infantile hemangioendothelioma treated with high dose methylprednisolone pulse therapy.
Eun Ae PARK ; Jung Wan SEO ; Sun Wha LEE ; Hae Young CHOI ; Seung Joo LEE
Journal of Korean Medical Science 2001;16(1):127-129
Infantile hemangioendothelioma is a severe disease with a high mortality. It is characterized by multiple hemangioma affecting the skin and visceral organs. We report that high doses of methylprednisolone pulse therapy improved symptoms and signs of infantile hemangioendothelioma in a male neonate, and completely resolved the hepatic and cutaneous hemangioendothelioma on follow up.
Case Report
;
Hemangioendothelioma/drug therapy*
;
Human
;
Infant, Newborn
;
Liver Neoplasms/drug therapy*
;
Male
;
Methylprednisolone/administration & dosage*
;
Skin Neoplasms/drug therapy*
3.Ruptured Undifferentiated (Embryonal) Sarcoma of the Liver in an Adult.
Sang Hyun SHIN ; Je Hoon PARK ; Seong Woo HONG ; Yun Kyung KANG ; Hyucksang LEE
Korean Journal of Hepato-Biliary-Pancreatic Surgery 2005;9(3):185-188
The undifferentiated (embryonal) sarcoma of the liver (USL) has previously been called malignant mesenchymoma, undifferentiated sarcoma and fibromyxosarcoma. USL was named as an entity by Stocker and Ishak in 1978 on the basis of an Armed Forces Institute of Pathology (AFIP) series of 31 cases. The USL is a rare primary neoplasm of a mesenchymal origin and it predominantly occurs in children. Stocker reported that it was fourth in frequency among the liver tumors of childhood, following hepatoblastoma, hemangioendothelioma and hepatocellular carcinoma. Although there has been controversy as to the most appropriate treatment, the studies have reported that long term survival is possible after complete surgical resection with or without perioperative chemotherapy. This tumor's frequency in the adult population is extremely low. We report here on a case of USL in an adult woman with the review of the relevant literature.
Adult*
;
Arm
;
Carcinoma, Hepatocellular
;
Child
;
Drug Therapy
;
Female
;
Hemangioendothelioma
;
Hepatoblastoma
;
Humans
;
Liver Neoplasms
;
Liver*
;
Mesenchymoma
;
Neoplasms, Germ Cell and Embryonal
;
Pathology
;
Sarcoma*
4.Pleural Epithelioid Hemangioendothelioma.
Young Joo LEE ; Moon Jae CHUNG ; Ki Cheon JEONG ; Chang Hoon HAHN ; Ki Pyo HONG ; Yee Jeong KIM ; Yong Tai KIM
Yonsei Medical Journal 2008;49(6):1036-1040
Epithelioid hemangioendothelioma (EHE) is a rare tumor of vascular origin. While it can be found in any tissue, it is most often found in lung and liver and usually has an intermediate behavior. EHEs originating from pleural tissue have been less frequently described than those from other sites. Furthermore, to date, all of the cited pleural EHEs were described as highly aggressive. In the present report, we describe a rare case of pleural EHE extending to lung and bone in a 31-year-old woman. The histological diagnosis was confirmed by both conventional examination and immunohistochemistry. Her disease stabilized during the 4th course of adriamycin (45mg/m2, day 1-3), dacarbazine (300mg/m2, day 1-3) and ifosfamide (2,500mg/m2, day 1-3) with mesna, and she survived for 10 months after the diagnosis.
Adult
;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Diagnosis, Differential
;
Factor VIII/metabolism
;
Female
;
Hemangioendothelioma, Epithelioid/*diagnosis/drug therapy/metabolism
;
Humans
;
Immunohistochemistry
;
Keratins/metabolism
;
Lung Neoplasms/diagnosis
;
Pleural Neoplasms/*diagnosis/drug therapy/metabolism
;
Vimentin/metabolism
5.Primary malignant bone neoplasm: a case report of dedifferentiated chondrosarcoma in the rib and review of the literature.
Jin-Rong LIN ; Wei-Min ZHANG ; Zhuo-Cai WANG
Chinese Journal of Cancer 2010;29(11):964-968
Dedifferentiated chondrosarcoma (DDCS) is a rare but highly malignant primary bone neoplasm, which is resistant to radiotherapy and chemotherapy. There remains uncertainly as to the best treatment of this disease and how to improve its prognosis. In this paper we reported a case of DDCS and reviewed the related literatures in order to provide references to throw a light on the histogenesis, diagnosis and therapy of this disease.
Adult
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Bone Neoplasms
;
diagnostic imaging
;
drug therapy
;
pathology
;
Chondrosarcoma
;
diagnostic imaging
;
drug therapy
;
pathology
;
Cisplatin
;
administration & dosage
;
Doxorubicin
;
administration & dosage
;
analogs & derivatives
;
Follow-Up Studies
;
Hemangioendothelioma
;
diagnostic imaging
;
drug therapy
;
secondary
;
Humans
;
Immunohistochemistry
;
Lung Neoplasms
;
diagnostic imaging
;
drug therapy
;
secondary
;
Male
;
Methotrexate
;
administration & dosage
;
Multimodal Imaging
;
Positron-Emission Tomography
;
Ribs
;
Tomography, X-Ray Computed
6.Primary Hepatic Tumors in Children: Clinical Experience in a Single Institution.
Hee Chul LEE ; Yoon Jeong KIM ; Jong Jin SEO ; Hyung Nam MOON ; Thad T GHIM
Korean Journal of Pediatric Hematology-Oncology 2000;7(2):269-277
PURPOSE: The frequency and clinical characteristics of primary childhood hepatic tumors diagnosed in a single institution were reviewed. Method: From January 1991 to June 2000, 33 patients were diagnosed with primary hepatic tumor. Retrospective analysis of the medical records of the various primary hepatic tumors was performed. RESULTS: Among the total of 33 patients with primary hepatic tumor, twenty five (76%) were malignant and eight (24%) were benign. The mean age of patients with hepatoblastoma (HB) was 32 months (12 of 16 patients were less than 3 years), 12.8 years in hepatocellular carcinoma (HCC) (all of them were older than 11 years), 2 months in hemangioendothelioma (HE), and 3 months in hamartoma. The ratio of male to female was 1:1 in HB, and 4:1 in HCC. The presence of hepatitis B infection was detected in 80% (4/5) of HCC and in 13% (2/16) of HB. The common presenting symptoms at diagnosis were the palpable mass, abdominal pain and jaundice. Many tumors were found incidentally without any presenting symptoms. Of 33 patients, 22 had involvement at right lobe. HCC had more necrosis and hemorrhage within the tumor than HB on imaging study. HE had a distinct feature of contrast enhancement increasing from the peripheral portion of the mass to central portion. Hamartoma showed a feature with multiple cysts and septums within the mass. To confirm the diagnosis, a tissue biopsy was done in 23 patients (70%). A significantly elevated level of serum alpha-fetoprotein (AFP) is found in 88% (mean 386,000 ng/mL) of HB cases and 100% (mean 369,000 ng/mL) of HCC. The mean AFP level in HB patients was 391,000 ng/mL at diagnosis, 52 ng/mL after the preoperative chemotherapy, 8.3 ng/mL at postoperative follow-up, and 2.8 ng/mL at completion of chemotherapy. In HCC, the AFP level decreased temporarily after chemotherapy or chemo- embolization, but increasesd at recurrence in most case. Patients resectable at the time of diagnosis or after preoperative chemotherapy were 12 (75%) in HB, and 10 of them are were alive with median the follow-up of 34 months (5 mo.~8 yrs 7 mo.). All the HCC patients were unresectable or had metastatic lesion at diagnosis, and all of them were assumed dead following discharge. Conclusions: Among the primary hepatic tumors in children, malignant tumors are more frequent than benign. Age of onset, AFP level and imaging studies all play an important role in diagnosis, and biopsy is usually confirmative. HCC has an extremely poor prognosis in childhood. HB patients with complete surgical resection enjoy a relatively high long term survival.
Abdominal Pain
;
Age of Onset
;
alpha-Fetoproteins
;
Biopsy
;
Carcinoma, Hepatocellular
;
Child*
;
Diagnosis
;
Drug Therapy
;
Female
;
Follow-Up Studies
;
Hamartoma
;
Hemangioendothelioma
;
Hemorrhage
;
Hepatitis B
;
Hepatoblastoma
;
Humans
;
Jaundice
;
Male
;
Medical Records
;
Necrosis
;
Prognosis
;
Recurrence
;
Retrospective Studies